Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:advocacy |
Patient Advocacy Network
Syndrome E Foundation |
| gptkbp:affects |
gptkb:chronic_fatigue_syndrome
emotional instability human beings persistent cognitive deficits |
| gptkbp:associated_symptom |
fatigue
sleep disturbances seizures headaches mood swings |
| gptkbp:associated_with |
neuroinflammation
|
| gptkbp:awareness_level |
low
|
| gptkbp:case_analysis |
clinical observations
documented in medical literature reported in journals |
| gptkbp:cause |
gptkb:disease
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:condition |
gptkb:multiple_sclerosis
|
| gptkbp:diagnosis |
gptkb:ICD-10
gptkb:DSM-5 clinical evaluation |
| gptkbp:first_described_by |
gptkb:2010
|
| gptkbp:funding |
limited
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syndrome E
|
| gptkbp:patient_population |
adults
elderly |
| gptkbp:prevalence |
rare
|
| gptkbp:public_perception |
misunderstood
stigmatized lacks recognition |
| gptkbp:research_areas |
gptkb:neurodegenerative_diseases
|
| gptkbp:research_challenge |
developing effective treatments
understanding etiology establishing diagnostic standards |
| gptkbp:research_focus |
neurology
|
| gptkbp:risk_factor |
genetic predisposition
environmental triggers autoimmune disorders |
| gptkbp:symptoms |
memory loss
behavioral changes cognitive impairment |
| gptkbp:treatment |
gptkb:pharmaceuticals
variable cognitive rehabilitation symptomatic management dependent on individual |
| gptkbp:bfsParent |
gptkb:Olivier_Norek
|
| gptkbp:bfsLayer |
8
|